scholarly journals Amide proton transfer-weighted MRI in the clinical setting – correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T

Radiography ◽  
2021 ◽  
Author(s):  
A.I. Friismose ◽  
L. Markovic ◽  
N. Nguyen ◽  
O. Gerke ◽  
M.K. Schulz ◽  
...  
2019 ◽  
Vol 61 (4) ◽  
pp. 549-557 ◽  
Author(s):  
Qingxu Song ◽  
Chencheng Zhang ◽  
Xin Chen ◽  
Yufeng Cheng

Background As a subtype of chemical exchange saturation transfer imaging without contrast agent administration, amide proton transfer (APT) imaging has demonstrated the potential for differentiating the histologic grades of gliomas. Dynamic susceptibility contrast-enhanced perfusion, a perfusion-weighted imaging technique, is a well-established technique in grading gliomas. Purpose To compare the ability of amide proton transfer and dynamic susceptibility contrast-enhanced imaging for predicting the grades of gliomas. Material and Methods A comprehensive literature search was performed independently by two observers to identify articles about the diagnostic performance of amide proton transfer and dynamic susceptibility contrast-enhanced perfusion in predicting the grade of gliomas. Summary estimates of diagnostic accuracy were obtained by using a random-effects model. Results Of 179 studies identified, 23 studies were included the analysis. Eight studies evaluated amide proton transfer and 16 studies evaluated dynamic susceptibility contrast-enhanced perfusion with the parameter rCBV. The pooled sensitivities and specificities of each study’s best performing parameter were 88% (95% confidence interval [CI] 74–95) and 89% (95% CI 78–95) for amide proton transfer, and 95% (95% CI 87–98), 88% (95% CI 81–93) for perfusion-weighted imaging–dynamic susceptibility contrast-enhanced perfusion, respectively. The pooled sensitivities and specificities for grading gliomas using the two most commonly evaluated parameters, were 92% (95% CI 80–97) and 90% (95% CI 75–96) for APTmax, and 97% (95% CI 91–99) and 87% (95% CI 80–92) for rCBVmax, respectively. Conclusion Considering the similar performance of APT and dynamic susceptibility contrast-enhanced (DSC) in predicting glioma grade, the former method appears preferable since it needs no contrast agent.


PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0122537 ◽  
Author(s):  
Alex Förster ◽  
Mansour Al-Zghloul ◽  
Hans U. Kerl ◽  
Johannes Böhme ◽  
Bettina Mürle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document